Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids?
Enriquez Merayo E (1), Sciascia S (2,3), Roccatello D (2,3), Cuadrado MJ (1).
(1a) Rheumatology Department , Clinica Universidad de Navarra , Madrid , Spain.
(2b) Center of Research of Immunopathology and Rare Diseases- Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences , University of Turin , Turin , Italy.
(3c) SCU Nephrology and Dialysis, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences , University of Turin , Turin , Italy.
Magazine: Expert Review of Clinical Immunology
Date: Oct 17, 2018Reumatología [SP]
Glucocorticoids (GCs) have traditionally been the center of systemic lupus erythematosus (SLE) treatment and they continue to be recommended by the EULAR and ACR as the first-line therapy for several autoimmune diseases [1–4].
In the last 30 years, the trend has been to add immunosup- pressive drugs in an effort to minimize GC side effects and at the same time to achieve better control of disease activ- ity .
Coinciding with the decrease in the use of GC, 5-year survival rate in patients with lupus nephritis has increased from 44% in 1953–1969 to 96% today [6,7].
Lupus low disease activity state includes prednisolone doses 7.5 as definition criteria, recognizing the deleterious effects of GC in SLE prognosis .
CITATION Expert Rev Clin Immunol. 2018 Oct 17:1-3. doi: 10.1080/1744666X.2018.1527219.
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.